age1 funds breakthrough longevity companies addressing the core challenges of the field. We help contrarian founders build generational biotech companies.
Our expertise is at the earliest stage possible. We are a next-generation fund accelerating the longevity paradigm shift. We value pragmatism, rigor, and optimism.
Launched from The Longevity Fund, we’ve backed some of the first longevity biotech companies to IPO and achieve clinical translation.
Our vision is to make aging and age-related diseases optional for all.
Company Details
Age1 Questions
Age1's website is age1.com
Age1's LinkedIn profile is https://www.linkedin.com/company/age1
Age1 has
11 employees.
View email and phone details for 11
employees at Age1.
Age1's industry is
Venture Capital and Private Equity Principals
Age1's top competitors are
Until,
Longevity Research Circle,
Autonomy Bio,
Longevc,
Apollo Health Ventures,
Overton,
Loyal,
The Longevity Fund,
Time Initiative,
Permanence Bio.
Age1's support email address is laura@age1.com
Age1's categories are Venture Capital and Private Equity Principals
Age1's founding year is 2023
